RE: Sales28 Mar 2023 09:16
I stated at the time I didn't believe he had bigger deals on the table.. Just had to come up with a feasible excuse.
Disappointed to see the RNS first thing, says to me "leaky ship" from those trades last thing yesterday.
No mention of lysatt being used for anything bar more human testing , thought it was a long shot.
Bit of a teaser with testing on humans ongoing, as if its an additional positive, but could be a negative.
No mention of any Croda income stream this year.
Thought sales growth of axis has jumped a bit which is good, and customer retention top drawer however even at current increase rates going to be 5 years before really meaningful numbers.
New distribution partner...certainly not "in the bag ", as some were saying, almost as if a major snag has been encountered. It does happen I'm afraid.
Overall, some good progress but underwhelming. Glad I sold 8 tenths of my holding above strike price, seems its not a stock to rule out, but certainly not there yet.
Looks like share price drop yesterday was fair, but may drop again today, as the purpose of the Dec fund raise has not been achieved.